跳至主要内容
临床试验/CTRI/2019/12/022332
CTRI/2019/12/022332尚未招募未知

A study to evaluate the effectiveness of adding an oral second generation, non sedating, H1 antihistamine (Fexofenadine) to topical treatment in achieving better clinical outcome in paediatric patients of atopic dermatitis

PGIMER Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Paediatric patients of atopic dermatitis between 6months to 14 years of age, irrespective of sex diagnosed as per the UK criteria
  • Patients with mild to moderate disease
  • Willing to come for regular follow up

排除标准

  • Patients with severe disease needing systemic therapy
  • Inability to come for follow up visits
  • Patients whose parents or guardians do not give valid consent

研究者

相似试验